Tratamiento de sangrado postoperatorio en cirugía cardiaca con ...

9. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with
recombinant factor VIIa. Lancet. 1999;354:1879
10. Harold R. Roberts, Dougald M. Monroe, Gilbert C. Whit. The use of recombinant
factor VIIa in the treatment of bleeding disorders. Blood. 2004;104: 3858-3864
11. Levi M, Peters M, Büller HR. Efficacy and safety of recombinant factor VIIa for
treatment of severe bleeding: A systematic review. Crit Care Med. 2005;33:883-
890.
12. Oliver Warren, MRCS, Kaushik Mandal, MS, MRCS, Vassilis Hadjianastassiou,
Recombinant Activated Factor VII in Cardiac Surgery: A Systematic Review. Ann
Thorac Surg. 2007;83:707–14
13. George J. Despotis, Michael S. Avidan, Charles W. Hogue. Mechanisms and
attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac
Surg. 2001;72:1821-31.
14. Moulton MJ, Creswell LL, Mackey ME, Cox JL. Rosenbloom M. Reexploration for
bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac
Cardiovasc Surg. 1996;111:1037–1046.
15. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive
blood loss with mortality in cardiac surgery. Transfusion. 2004;44:1453-1462.
16. Karthik S, Grayson AD, McCarron EE, et al. Reexploration for bleeding after coronary
artery bypass surgery: Risk factors, outcomes, and the effect of time delay. Ann
Thorac Surg. 2003;78:527-534.
17. Despotis GJ, Filos KS, Zoys TN et al. Factors associated with excessive postoperative
blood loss and hemostatic transfusion requirements: A multivariate analysis in
cardiac surgical patients. Anesth Analg 1996;82:13–21.
46